UNSPSC 51113501: Pipobroman

This classification denotes an antineoplastic alkylating agent with the molecular formula C10H16Br2N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6Q99RDT97R, chemically known as 1,4-bis(3-bromopropionyl)piperazine but more generally known as pipobroman, which bears US NIH Compound Identifier 4842. European Medicines Agency schedules Pipobroman in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09875MIG. The term PIPOBROMAN is an International Non-Proprietary Name.

UNSPSC 51113501 Pipobroman is a Commodity code covering a specific pharmaceutical active ingredient used in certain chemotherapy and immunosuppressive treatments. State and local governments procure pipobroman through pharmacy benefit management systems, health department pharmaceutical acquisition programs, and institutional healthcare procurement channels, typically as part of bulk pharmaceutical supply contracts or specialty drug formularies for public hospitals, correctional healthcare systems, and safety-net clinics. The code covers the drug substance itself rather than finished pharmaceutical formulations, and procurement is often bundled with other oncologic or immunologic agents under broader pharmaceutical supply agreements.

The source provided contains no recent state and local contract opportunities, solicitation notices, issuing-body identifiers, or geographic activity data for this code. Without posted RFP, RFQ, IFB, or ITB activity in the recent-opportunities block, no representative procurement examples, issuing-body patterns, or state-level concentration can be characterized. Pipobroman is a niche pharmaceutical with limited modern clinical use in U.S. public healthcare systems, which may account for the absence of visible solicitation activity in state and local procurement channels.